发明名称 |
Methods for inhibiting the development of Huntington's disease |
摘要 |
This invention relates to Huntington's disease and more specifically to methods for inhibiting the development of or treating Huntington's disease by administering estrogen, testosterone, precursors thereof or combinations thereof. |
申请公布号 |
US9389237(B2) |
申请公布日期 |
2016.07.12 |
申请号 |
US201414334643 |
申请日期 |
2014.07.17 |
申请人 |
Carnazza James A. |
发明人 |
Carnazza James A. |
分类号 |
A61K31/56;A61K31/57;G01N33/74;A61P25/14;C12Q1/68;G01N33/68;A61K31/565;A61K31/568 |
主分类号 |
A61K31/56 |
代理机构 |
AGG Intellectual Property Law |
代理人 |
Giugliano Antoinette G.;AGG Intellectual Property Law |
主权项 |
1. A method of determining if administration of 17β-estradiol or testosterone is needed in an individual having a Huntington's Disease (HD) gene with a number of CAG repeats between about 36 and about 120, the method comprising:
a. determining a level is below normal when the level is less than about 100 pg/ml for 17β-estradiol, less than about 20 pg/ml for free testosterone, or less than about 300 ng/dL for total testosterone; and b. administering an amount of 17β-estradiol or an amount of testosterone when the level is below normal; wherein determining the level of 17β-estradiol and the need to administer an amount of 17β-estradiol are for a female individual, and wherein determining the level of free testosterone or total testosterone and the need to administer an amount of testosterone are for a male individual. |
地址 |
Holden MA US |